Our Team

Here is why our team is capable of bringing The Blue Box through CE Mark and industrialization, and launch it into the market by 2026.

JUDIT Giró BENET
Co-founder & CEO

Worked as Specialist
Univ. of California Irvine

(Msc) on Embedded Cyber-physical Systems
Univ. of California Irvine

(BSc) Biomedical Eng.
University of Barcelona

LIDIA NAVARRO FARRE, PhD.
Co-founder & COO

Project Manager dealing with EU projects
Consulting Company

PhD in thermal energy storage
University of Lleida

Sara MORERA ROCA
Product Lead

(BSc) Industrial Designer and Product Developer

(Msc) on Biomedical Engineering
University of Barcelona

JÚLIA SOLANA BALAGUER, PhD.
Clinical Lead

(BA) Biochemistry & Biomedical Sciences
Univ. Valencia

(Msc) on Neuroscience
Univ. Barcelona, Rovira i Virgili & Lleida

PhD in Biomedicine
Univ. Barcelona

Courses in Management of Clinical Trials & Clinical Drug Devolpment

ARNAU BASSOLS NOGUER
R&D Engineer

(BSc) Biomedical Eng.

University Politècnica de Catalunya

Politecnico di Milano

SILVIA BUENO MEGIAS
Lab Technician

(BSc) Chemistry

University of Barcelona

ANDREA AVILA CARDOZO
EA & Project Manager

(BA) Executive Assistance

University of Navarra

Clinical and Go-to-market Advisors

MIRIAM DE LA FLOR, MD

OB-GYN chief, Joan XXIII Hospital

JOSE I. SÁNCHEZ MÉNDEZ, MD

OB-GYN chief, La Paz Hospital

SONIA BAULIES, MD

OB-GYN chief, Dexeus Women’s Clinic

Scientific Advisors

PROF. FADi KURDAHI, PhD.

Director of the Center for Embedded Cyber-physical Systems, UCI

TONI PARDO, PhD.

Department of Biochemical Eng. and Electronics, Univ. Barcelona

Mentors / Shareholders

Torsten Kolind

Femtech Investor & Founder, YouNoodle

Robert Masse

Founder & CEO, Loyaltek

Key Opinion Leaders are Supporting Us

“The Blue Box will offer a step forward in addressing the diagnostic challenges of breast cancer in young women, who have dense breast tissue. This novel solution holds promise in providing a reliable means of diagnosing breast cancer in this specific population, wherein conventional tools have shown suboptimal sensitivity performance.”

Míriam de la Flor, MD

Chief of Gynaecology and Obstetrics Joan XXIII University Hospital, Tarragona

“WomEC will revolutionize uterine cancer diagnosis in the world”

Javier F. Magrina,

Director Gynecologic Oncology

“From a clinical perspective, the project is expected to benefit the European community”

Frederic Amant,

Head of the gynecology oncology department, ex-chairman of the ENITEC consortium

Join The Blue Box Family!

Do you want to be the first to know when The Blue Box will hit the market?

Subscribe to our newsletter and never miss out on The Blue Box journey!

Helping women get Breast Cancer tested.

Please be advised that this device is in the development and certification phase and is not yet a medical device.

Contents

Legal

EU Headquarters

The Blue Box Biomedical Solutions, S.L.

C. Pasqual i Vila s/n,
StartUB! Universitat de Barcelona
08029, Barcelona
(Spain)

hello@thebluebox.ai

USA Headquarters

The Blue Box Biomedical Solutions Inc.

700 El Camino Real (Suite 120-1018)

94025 Menlo Park,

CA (USA)

+1 (650) 248-0887

hello@thebluebox.ai

Funded by the European Union with the Digital Kit program by the Next Generation (EU) funds of the Recovery and Resilience Mechanism

Copyright 2025 | The Blue Box Biomedical Solutions, S.L.